CD9 and neoplasm: A study comparing stromal stem cells (menstrual blood-derived) from females with EMs and non-EMs found higher CD9, CD10, and CD29 expression levels in women with EMs (Nikoo et al., 2014), suggesting that EMs share the same properties as tumor cells, namely the invasive growth of diseased tissue.